Artículos por temáticas

Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease

Belbin O, Carrasquillo MM, Crump M, Culley OJ, Hunter TA, Ma L, Bisceglio G, Zou F, Allen M, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG.

Hum Genet. 2011 Mar;129(3):273-82. doi: 10.1007/s00439-010-0924-2. Epub 2010 Dec 4.

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Bartzokis G.

Neurobiol Aging. 2011 Aug;32(8):1341-71. doi: 10.1016/j.neurobiolaging.2009.08.007. Epub 2009 Sep 22.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. doi: 10.2174/187152711794488665.

Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis

Whitwell JL, Jack CR Jr, Przybelski SA, Parisi JE, Senjem ML, Boeve BF, Knopman DS, Petersen RC, Dickson DW, Josephs KA.

Neurobiol Aging. 2011 Sep;32(9):1531-41. doi: 10.1016/j.neurobiolaging.2009.10.012. Epub 2009 Nov 14.

Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease

Li C, Zhao R, Gao K, Wei Z, Yin MY, Lau LT, Chui D, Yu AC.

Curr Alzheimer Res. 2011 Feb;8(1):67-80. doi: 10.2174/156720511794604543.

Voltage-dependent anion channel as a resident protein of lipid rafts: post-transductional regulation by estrogens and involvement in neuronal preservation against Alzheimer's disease

Herrera JL, Diaz M, Hernández-Fernaud JR, Salido E, Alonso R, Fernández C, Morales A, Marin R.

J Neurochem. 2011 Mar;116(5):820-7. doi: 10.1111/j.1471-4159.2010.06987.x. Epub 2011 Jan 7.

Postgenomics, uncertain futures, and the familiarization of susceptibility genes

Chilibeck G, Lock M, Sehdev M.

Soc Sci Med. 2011 Jun;72(11):1768-75. doi: 10.1016/j.socscimed.2010.01.053. Epub 2010 May 8.

Overview and recent advances in neuropathology. Part 2: Neurodegeneration

Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, McLean C.

Pathology. 2011 Feb;43(2):93-102. doi: 10.1097/PAT.0b013e3283426eee.

Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease

Camandola S, Mattson MP.

Biochim Biophys Acta. 2011 May;1813(5):965-73. doi: 10.1016/j.bbamcr.2010.10.005. Epub 2010 Oct 13.

Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease

Penzes P, Vanleeuwen JE.

Brain Res Rev. 2011 Jun 24;67(1-2):184-92. doi: 10.1016/j.brainresrev.2011.01.003. Epub 2011 Jan 26.

APP transgenic mice: their use and limitations

Balducci C, Forloni G.

Neuromolecular Med. 2011 Jun;13(2):117-37. doi: 10.1007/s12017-010-8141-7. Epub 2010 Dec 9.

Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment

Wattmo C, Wallin ÅK, Londos E, Minthon L.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):63-72. doi: 10.1097/WAD.0b013e3181f5dd97.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease

Bonner JM, Boulianne GL.

Exp Gerontol. 2011 May;46(5):335-9. doi: 10.1016/j.exger.2010.08.004. Epub 2010 Aug 16.

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease

Chance SA, Clover L, Cousijn H, Currah L, Pettingill R, Esiri MM.

Cereb Cortex. 2011 Aug;21(8):1870-8. doi: 10.1093/cercor/bhq264. Epub 2011 Jan 14.